Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.032. Epub 2021 Jul 28.

Authors

Affiliations

¹ Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Institut Pasteur Korea, Seongnam-si, Gyeonggi-do, Republic of Korea.
³ Institut Pasteur Korea, Seongnam-si, Gyeonggi-do, Republic of Korea. Electronic address: youngmee.jee@ip-korea.org.
⁴ Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: kimsunghanmd@hotmail.com.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
COVID-19*
Humans
Immunity
SARS-CoV-2

Substances

Antibodies, Neutralizing
Antibodies, Viral